$GYRE
GYRE THERAPEUTICS, INC.

2015 Q1 Form 10-K Financial Statement

#000119312515093871 Filed on March 16, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q4 2014 Q3
Revenue $60.00K $127.0K $25.00K
YoY Change -31.03% 36.56%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.320M $1.080M $850.0K
YoY Change -15.94% -59.25% -69.96%
% of Gross Profit
Research & Development $1.383M $1.400M $1.336M
YoY Change -84.77% -86.98% -87.04%
% of Gross Profit
Depreciation & Amortization $113.0K $400.0K $200.0K
YoY Change 63.77% 100.0%
% of Gross Profit
Operating Expenses $3.704M $2.470M $2.185M
YoY Change 71.48% -81.57% -83.38%
Operating Profit -$3.032M -$1.798M -$1.638M
YoY Change 62.75% -86.49% -87.54%
Interest Expense $170.0K $500.0K $5.000K
YoY Change 1788.89% 212.5% -61.54%
% of Operating Profit
Other Income/Expense, Net $92.00K $139.0K
YoY Change -45.56% -43.03%
Pretax Income -$6.731M -$1.300M -$4.849M
YoY Change -41.91% -90.27% -62.42%
Income Tax $21.00K $11.00K
% Of Pretax Income
Net Earnings -$2.858M -$1.302M -$1.502M
YoY Change 64.82% -90.26% -88.36%
Net Earnings / Revenue -4763.33% -1025.2% -6008.0%
Basic Earnings Per Share -$0.14 -$0.14
Diluted Earnings Per Share -$143.0M -$65.00M -$75.00M
COMMON SHARES
Basic Shares Outstanding 33.79M shares 34.31M shares 33.79M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 Q4 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $104.8M $1.500M $97.90M
YoY Change 7.82% -98.37% 1.14%
Cash & Equivalents $2.069M $1.544M $3.603M
Short-Term Investments $31.60M $0.00 $52.20M
Other Short-Term Assets $400.0K $400.0K $1.000M
YoY Change -55.56% -60.0% -44.44%
Inventory
Prepaid Expenses $409.0K $615.0K $1.016M
Receivables $100.0K $100.0K $100.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $105.2M $2.070M $98.99M
YoY Change 6.86% -97.79% 0.4%
LONG-TERM ASSETS
Property, Plant & Equipment $373.0K $911.0K $483.0K
YoY Change -38.95% 33.58% -35.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.500M $16.60M
YoY Change -95.7% -71.58%
Other Assets $9.000K $12.00K $19.00K
YoY Change -66.67% -70.0% -63.46%
Total Long-Term Assets $1.900M $911.0K $17.13M
YoY Change -94.67% -98.26% -71.09%
TOTAL ASSETS
Total Short-Term Assets $105.2M $2.070M $98.99M
Total Long-Term Assets $1.900M $911.0K $17.13M
Total Assets $107.1M $2.981M $116.1M
YoY Change -20.11% -97.96% -26.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.189M $249.0K $364.0K
YoY Change 2.68% -80.79% -82.46%
Accrued Expenses $2.714M $2.509M $2.370M
YoY Change -65.51% -71.59% -69.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $478.0K
YoY Change -45.25%
Total Short-Term Liabilities $3.903M $2.336M $3.212M
YoY Change -60.44% -78.72% -69.8%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities $1.100M
YoY Change
Total Long-Term Liabilities $0.00 $1.100M $0.00
YoY Change -100.0% 288.69% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.903M $2.336M $3.212M
Total Long-Term Liabilities $0.00 $1.100M $0.00
Total Liabilities $3.903M $3.456M $3.212M
YoY Change -61.0% -69.31% -71.1%
SHAREHOLDERS EQUITY
Retained Earnings -$320.0M -$116.3M -$308.6M
YoY Change 8.25% -58.57% 15.48%
Common Stock $34.00K $34.00K $34.00K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $103.2M -$109.4M $112.9M
YoY Change
Total Liabilities & Shareholders Equity $107.1M $2.981M $116.1M
YoY Change -20.11% -97.96% -26.43%

Cashflow Statement

Concept 2015 Q1 2014 Q4 2014 Q3
OPERATING ACTIVITIES
Net Income -$2.858M -$1.302M -$1.502M
YoY Change 64.82% -90.26% -88.36%
Depreciation, Depletion And Amortization $113.0K $400.0K $200.0K
YoY Change 63.77% 100.0%
Cash From Operating Activities -$3.000M $25.00M -$7.600M
YoY Change -79.79% -323.21% -21.65%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $200.0K -$19.50M $10.20M
YoY Change -89.47% -600.0% 18.6%
Cash From Investing Activities $200.0K -$19.50M $10.20M
YoY Change -89.66% -600.0% 18.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $93.00K
YoY Change -65.93%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.300M 1.900M -200.0K
YoY Change -4.82% -2000.0% 100.0%
NET CHANGE
Cash From Operating Activities -3.000M 25.00M -7.600M
Cash From Investing Activities 200.0K -19.50M 10.20M
Cash From Financing Activities 3.300M 1.900M -200.0K
Net Change In Cash 500.0K 7.400M 2.400M
YoY Change -105.29% -200.0% -300.0%
FREE CASH FLOW
Cash From Operating Activities -$3.000M $25.00M -$7.600M
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$3.000M $25.00M -$7.600M
YoY Change -79.79% -323.21% -21.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33793735 shares
CY2014Q2 dei Entity Public Float
EntityPublicFloat
101556374
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
174288000
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1474000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
107283000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
175915000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1474000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
82240000
CY2012Q4 trgt Book Value Of Property Plant And Equipment Sold
BookValueOfPropertyPlantAndEquipmentSold
1534000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33718179 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33718179 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.93
CY2013Q4 us-gaap Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
4539337 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1357654 shares
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
4.04
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
999000
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
89111000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
40000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
93606000
CY2013Q4 trgt Deferred Tax Assets Intangible Assets
DeferredTaxAssetsIntangibleAssets
1641000
CY2013Q4 trgt Deferred Tax Assets Collaboration Revenue
DeferredTaxAssetsCollaborationRevenue
0
CY2013Q4 trgt Book Value Of Property Plant And Equipment Sold
BookValueOfPropertyPlantAndEquipmentSold
519000
CY2013Q4 trgt Accrued Clinical And Nonclinical Study Costs
AccruedClinicalAndNonclinicalStudyCosts
7578000
CY2013Q4 trgt Accrued Compensation Current
AccruedCompensationCurrent
1200000
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4539628 shares
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
101211000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1878000
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10979000
CY2013Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
191000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
34000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
87000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1296000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-280633000
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
853000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8830000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
134611000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
52000
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
283000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
145873000
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
199000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
415123000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1476000
CY2013Q4 us-gaap Liabilities
Liabilities
11262000
CY2013Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
196000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54485000
CY2013Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
296000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
682000
CY2013Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
278000
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
89292000
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
101402000
CY2013Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
57485000
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
36000
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
97000
CY2013Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
15000
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
12044000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
6498000
CY2013Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
37844000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2560000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
81183000
CY2013Q4 us-gaap Assets
Assets
145873000
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
191000
CY2013Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
51448000
CY2014Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
141000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34306435 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33793735 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.93
CY2014Q4 us-gaap Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
3883974 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1045162 shares
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.50
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
10.49
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3883974 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2838812 shares
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
116237000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1671000
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2914000
CY2014Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
101000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
34000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
405000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-313256000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2509000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
109085000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
28000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
393000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
12000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
111999000
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
296000
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
422303000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1317000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
25000
CY2014Q4 us-gaap Liabilities
Liabilities
2914000
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
33000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
356000
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
0
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56430000
CY2014Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
296000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
428000
CY2014Q4 trgt Book Value Of Property Plant And Equipment Sold
BookValueOfPropertyPlantAndEquipmentSold
4000
CY2014Q4 trgt Accrued Clinical And Nonclinical Study Costs
AccruedClinicalAndNonclinicalStudyCosts
1891000
CY2014Q4 trgt Accrued Compensation Current
AccruedCompensationCurrent
590000
CY2012Q2 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.46 pure
CY2012Q2 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
65 Employee
CY2012Q2 us-gaap Severance Costs1
SeveranceCosts1
2312000
CY2012Q4 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.38 pure
CY2014Q4 us-gaap Assets Current
AssetsCurrent
108141000
CY2014Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
615000
CY2014Q4 trgt Deferred Tax Assets Intangible Assets
DeferredTaxAssetsIntangibleAssets
1500000
CY2014Q4 trgt Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
2 EquityPlan
CY2014Q4 trgt Operating Leases Future Minimum Payments Due In Four Years And Thereafter
OperatingLeasesFutureMinimumPaymentsDueInFourYearsAndThereafter
0
CY2014Q4 trgt Deferred Tax Assets Collaboration Revenue
DeferredTaxAssetsCollaborationRevenue
0
CY2014Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
54373000
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
116338000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
1000
CY2014Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
52324000
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
26000
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7000
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
12739000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7317000
CY2014Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
50955000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2099000
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
94756000
CY2014Q4 us-gaap Assets
Assets
111999000
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
101000
CY2014Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
3418000
CY2014Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
54347000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
3915000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12000
CY2012Q4 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
27 Employee
CY2012Q4 us-gaap Severance Costs1
SeveranceCosts1
1406000
CY2012Q4 trgt Agreement Expiration Date
AgreementExpirationDate
2015-12-30
CY2012Q4 trgt Subleased Agreement Area
SubleasedAgreementArea
18282 sqft
CY2012Q4 trgt Agreement Entry Date
AgreementEntryDate
2013-01-01
CY2012Q4 trgt Sublease Agreement Base Monthly Rent
SubleaseAgreementBaseMonthlyRent
23000
CY2008Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
1679000
CY2013 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.04 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.06 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.01 pure
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-40612000
CY2013 us-gaap Investment Income Net
InvestmentIncomeNet
784000
CY2013 us-gaap Interest Paid
InterestPaid
56000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
92000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-46705000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M23D
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.04 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.011 pure
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33640323 shares
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.37 pure
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.39
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.04 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.82 pure
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4364064 shares
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.01 pure
CY2013 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
2000
CY2013 us-gaap Revenue From Grants
RevenueFromGrants
93000
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
17110000
CY2013 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
851000
CY2013 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
57551000
CY2013 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-226000
CY2013 us-gaap License And Services Revenue
LicenseAndServicesRevenue
3536000
CY2013 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-527000
CY2013 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-213000
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
299000
CY2013 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-114000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-47216000
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46819000
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
518000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-46698000
CY2013 us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
3536000
CY2013 us-gaap Revenues
Revenues
3629000
CY2013 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-213000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5216000
CY2013 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-114000
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7000
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
547000
CY2013 us-gaap Interest Expense
InterestExpense
53000
CY2013 us-gaap Operating Expenses
OperatingExpenses
50845000
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38840000
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1010000
CY2013 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
908000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-27755000
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
582000
CY2013 us-gaap Depreciation
Depreciation
505000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-552000
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
299000
CY2013 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1170000
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
13409000
CY2013 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
7000
CY2013 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
275000
CY2013 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
7000
CY2013 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
69882000
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12005000
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1985000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
5216000
CY2013 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-18076000
CY2013 trgt Deferred Tax Assets Valuation Allowances
DeferredTaxAssetsValuationAllowances
17073000
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.03 pure
CY2014 dei Entity Registrant Name
EntityRegistrantName
TARGACEPT INC
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Trading Symbol
TradingSymbol
TRGT
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
3.82
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.93
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.04 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.12 pure
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-34483000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.85
CY2014 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2014 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
1997-03-07
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M17D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
526475 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
935368 shares
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y11M23D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
721385 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.018 pure
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Use of Estimates</i></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with U.S. generally accepted accounting principles, or GAAP, requires management to make estimates and assumptions that affect the amounts of assets, liabilities, revenues and expenses reported in the financial statements and accompanying notes. Actual results could differ from these estimates.</font></p> </div>
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33780433 shares
CY2014 invest Investment Maturity Date Range Start1
InvestmentMaturityDateRangeStart1
2015-01-09
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.52 pure
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y2M16D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
4.75
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.53
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0001124105
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.97
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.02 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1515466 shares
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.68
CY2014 invest Investment Maturity Date Range End1
InvestmentMaturityDateRangeEnd1
2016-12-12
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.11 pure
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4683263 shares
CY2014 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 18px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Credit Risk</i></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Financial instruments that potentially subject the Company to credit risk consist principally of cash, investments in marketable securities and receivables from collaborations. The Company has established guidelines for investment of its cash that are designed to emphasize safety, liquidity and preservation of capital. The Company places its cash and cash equivalents with prominent financial institutions. At December&#xA0;31, 2014 and 2013, the Company had deposits in excess of federally insured limits of $52,324,000 and $57,485,000, respectively.</font></p> </div>
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.01 pure
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
33856000
CY2014 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
72000
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3412000
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
3412000
CY2014 us-gaap Depreciation
Depreciation
254000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2572000
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
75556 shares
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-159000
CY2014 us-gaap Revenue From Grants
RevenueFromGrants
275000
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
15026000
CY2014 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1136000
CY2014 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
7169000
CY2014 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-131000
CY2014 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-147000
CY2014 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-565000
CY2014 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
14000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
296000
CY2014 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-83000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-29714000
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
296000
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
38000
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32706000
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
575000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-29139000
CY2014 us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
148000
CY2014 us-gaap Revenues
Revenues
275000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-32623000
CY2014 us-gaap Investment Income Net
InvestmentIncomeNet
585000
CY2014 us-gaap Interest Paid
InterestPaid
26000
CY2014 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
13000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3472000
CY2014 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
3412000
CY2014 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-83000
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
72000
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
351000
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
148000
CY2014 us-gaap Interest Expense
InterestExpense
23000
CY2014 us-gaap Operating Expenses
OperatingExpenses
29989000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19499000
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1488000
CY2014 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3412000
CY2014 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
775000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1945000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3484000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
541000
CY2014 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
194000
CY2014 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
8000
CY2014 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
72000
CY2014 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
40991000
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10172000
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7212000
CY2014 us-gaap Severance Costs1
SeveranceCosts1
318000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
3472000
CY2014 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-13477000
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2014 trgt Weighted Average Maturity Date
WeightedAverageMaturityDate
2015-06-24
CY2014 trgt Effective Income Tax Rate Reconciliation Revaluation Of Unrecognized Tax Benefits Reserve Requirements
EffectiveIncomeTaxRateReconciliationRevaluationOfUnrecognizedTaxBenefitsReserveRequirements
0.01 pure
CY2014 trgt Deferred Tax Assets Valuation Allowances
DeferredTaxAssetsValuationAllowances
15037000
CY2012 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.04 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.01 pure
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-64239000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M28D
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.02 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.010 pure
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33476316 shares
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.25 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.04 pure
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.69 pure
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4250964 shares
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.15 pure
CY2012 us-gaap Revenue From Grants
RevenueFromGrants
440000
CY2012 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1240000
CY2012 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
120972000
CY2012 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1162000
CY2012 us-gaap License And Services Revenue
LicenseAndServicesRevenue
57420000
CY2012 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2017000
CY2012 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
55000
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
614000
CY2012 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
165000
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-8138000
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6833000
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1039000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7099000
CY2012 us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
57860000
CY2012 us-gaap Revenues
Revenues
57860000
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
333000
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-6998000
CY2012 us-gaap Investment Income Net
InvestmentIncomeNet
1070000
CY2012 us-gaap Interest Paid
InterestPaid
91000
CY2012 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
55000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7846000
CY2012 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
165000
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-101000
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2212000
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
440000
CY2012 us-gaap Interest Expense
InterestExpense
86000
CY2012 us-gaap Operating Expenses
OperatingExpenses
65998000
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49087000
CY2012 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-718000
CY2012 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
937000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-25043000
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-101000
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2819000
CY2012 us-gaap Depreciation
Depreciation
2195000
CY2012 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-626000
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
614000
CY2012 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1589000
CY2012 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2012 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
39822000
CY2012 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
-101000
CY2012 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
454000
CY2012 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-101000
CY2012 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
159538000
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13193000
CY2012 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-11515000
CY2012 us-gaap Severance Costs1
SeveranceCosts1
3718000
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
7846000
CY2012 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2012 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1128000
CY2012 trgt Deferred Tax Assets Valuation Allowances
DeferredTaxAssetsValuationAllowances
1745000
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33616342 shares
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8274000
CY2013Q1 us-gaap Revenues
Revenues
3536000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-8066000
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33746917 shares
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-11756000
CY2014Q1 us-gaap Revenues
Revenues
87000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-14999000
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33626980 shares
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-12488000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-12371000
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33786686 shares
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8239000
CY2014Q2 us-gaap Revenues
Revenues
36000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-8136000
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33644256 shares
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-13146000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-12902000
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33793735 shares
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4988000
CY2014Q3 us-gaap Revenues
Revenues
25000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-4860000
CY2013Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33673047 shares
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-13308000
CY2013Q4 us-gaap Revenues
Revenues
93000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-13366000
CY2014Q4 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.26 pure
CY2014Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33793735 shares
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2014Q4 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
7 Employee
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4731000
CY2014Q4 us-gaap Revenues
Revenues
127000
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-4628000
CY2014Q4 us-gaap Severance Costs1
SeveranceCosts1
318000

Files In Submission

Name View Source Status
0001193125-15-093871-index-headers.html Edgar Link pending
0001193125-15-093871-index.html Edgar Link pending
0001193125-15-093871.txt Edgar Link pending
0001193125-15-093871-xbrl.zip Edgar Link pending
d856974d10k.htm Edgar Link pending
d856974dex1024.htm Edgar Link pending
d856974dex104e.htm Edgar Link pending
d856974dex231.htm Edgar Link pending
d856974dex311.htm Edgar Link pending
d856974dex312.htm Edgar Link pending
d856974dex321.htm Edgar Link pending
d856974dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g856974g03e57.jpg Edgar Link pending
g856974g63h97.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
trgt-20141231.xml Edgar Link completed
trgt-20141231.xsd Edgar Link pending
trgt-20141231_cal.xml Edgar Link unprocessable
trgt-20141231_def.xml Edgar Link unprocessable
trgt-20141231_lab.xml Edgar Link unprocessable
trgt-20141231_pre.xml Edgar Link unprocessable